Rank | Gene Set | Z-score |
---|---|---|
1 | mature B cell differentiation involved in immune response (GO:0002313) | 7.19689192 |
2 | positive regulation of growth hormone secretion (GO:0060124) | 7.13320572 |
3 | definitive hemopoiesis (GO:0060216) | 6.69091376 |
4 | * aggressive behavior (GO:0002118) | 6.55732666 |
5 | Peyers patch development (GO:0048541) | 6.43480599 |
6 | mucosal-associated lymphoid tissue development (GO:0048537) | 6.43480599 |
7 | negative regulation of digestive system process (GO:0060457) | 6.18993357 |
8 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 6.06483624 |
9 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 5.99409431 |
10 | synaptic vesicle maturation (GO:0016188) | 5.88929020 |
11 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.84548942 |
12 | regulation of gonadotropin secretion (GO:0032276) | 5.55587309 |
13 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.47506224 |
14 | mature B cell differentiation (GO:0002335) | 5.45331192 |
15 | negative regulation of necrotic cell death (GO:0060547) | 5.44639364 |
16 | regulation of growth hormone secretion (GO:0060123) | 5.31922340 |
17 | locomotory exploration behavior (GO:0035641) | 5.24451572 |
18 | response to dietary excess (GO:0002021) | 5.16735616 |
19 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 5.12796129 |
20 | seminiferous tubule development (GO:0072520) | 5.02373306 |
21 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.98787324 |
22 | regulation of beta-amyloid formation (GO:1902003) | 4.92605300 |
23 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.90182952 |
24 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.87104255 |
25 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.82261391 |
26 | respiratory system process (GO:0003016) | 4.82218615 |
27 | neurotransmitter secretion (GO:0007269) | 4.81224718 |
28 | neuromuscular process controlling posture (GO:0050884) | 4.79108236 |
29 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.78343027 |
30 | positive regulation of prostaglandin secretion (GO:0032308) | 4.76682838 |
31 | vocalization behavior (GO:0071625) | 4.70733501 |
32 | activation of protein kinase A activity (GO:0034199) | 4.69051996 |
33 | neuron cell-cell adhesion (GO:0007158) | 4.69020743 |
34 | gamma-aminobutyric acid transport (GO:0015812) | 4.64623977 |
35 | mitochondrial calcium ion transport (GO:0006851) | 4.63845023 |
36 | metallo-sulfur cluster assembly (GO:0031163) | 4.56588301 |
37 | iron-sulfur cluster assembly (GO:0016226) | 4.56588301 |
38 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.53448321 |
39 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 4.51932800 |
40 | endothelium development (GO:0003158) | 4.45969706 |
41 | response to pheromone (GO:0019236) | 4.39324640 |
42 | positive regulation of vascular permeability (GO:0043117) | 4.25450241 |
43 | axonal fasciculation (GO:0007413) | 4.24612864 |
44 | neurotransmitter catabolic process (GO:0042135) | 4.20219598 |
45 | proline transport (GO:0015824) | 4.15529206 |
46 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.12869932 |
47 | regulation of synaptic vesicle transport (GO:1902803) | 4.09578223 |
48 | negative regulation of cell size (GO:0045792) | 4.09111761 |
49 | neurotransmitter transport (GO:0006836) | 4.08204468 |
50 | layer formation in cerebral cortex (GO:0021819) | 4.07321384 |
51 | pyrimidine nucleotide catabolic process (GO:0006244) | 4.03428801 |
52 | protein localization to synapse (GO:0035418) | 4.02922818 |
53 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.00424562 |
54 | response to interferon-beta (GO:0035456) | 3.99328316 |
55 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.98870051 |
56 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 3.95078946 |
57 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 3.95078946 |
58 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.88905504 |
59 | purine nucleotide salvage (GO:0032261) | 3.87729107 |
60 | regulation of prostaglandin secretion (GO:0032306) | 3.83862220 |
61 | negative regulation of B cell apoptotic process (GO:0002903) | 3.82414013 |
62 | cellular response to exogenous dsRNA (GO:0071360) | 3.82405243 |
63 | glutamate secretion (GO:0014047) | 3.82132521 |
64 | * protein kinase C signaling (GO:0070528) | 3.80964174 |
65 | regulation of neurotransmitter levels (GO:0001505) | 3.80637016 |
66 | regulation of necrotic cell death (GO:0010939) | 3.79643963 |
67 | synaptic vesicle exocytosis (GO:0016079) | 3.79365212 |
68 | neuron recognition (GO:0008038) | 3.76508180 |
69 | cerebellar Purkinje cell layer development (GO:0021680) | 3.76110398 |
70 | vesicle transport along microtubule (GO:0047496) | 3.73716218 |
71 | deoxyribonucleotide catabolic process (GO:0009264) | 3.73457134 |
72 | cellular hyperosmotic response (GO:0071474) | 3.72903008 |
73 | post-embryonic morphogenesis (GO:0009886) | 3.72057217 |
74 | exploration behavior (GO:0035640) | 3.72053317 |
75 | regulation of cellular amide metabolic process (GO:0034248) | 3.70121069 |
76 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.69707492 |
77 | cellular potassium ion homeostasis (GO:0030007) | 3.69426260 |
78 | estrogen biosynthetic process (GO:0006703) | 3.69317299 |
79 | base-excision repair, AP site formation (GO:0006285) | 3.67174797 |
80 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.65419254 |
81 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.63974209 |
82 | sodium ion export (GO:0071436) | 3.61804900 |
83 | mating behavior (GO:0007617) | 3.61487320 |
84 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.60568675 |
85 | regulation of penile erection (GO:0060405) | 3.58827741 |
86 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.58693632 |
87 | mitochondrion transport along microtubule (GO:0047497) | 3.58693632 |
88 | cellular response to interferon-beta (GO:0035458) | 3.55342553 |
89 | axon cargo transport (GO:0008088) | 3.54798922 |
90 | response to histamine (GO:0034776) | 3.53231443 |
91 | negative regulation of response to food (GO:0032096) | 3.52350063 |
92 | negative regulation of appetite (GO:0032099) | 3.52350063 |
93 | daunorubicin metabolic process (GO:0044597) | 3.50365447 |
94 | polyketide metabolic process (GO:0030638) | 3.50365447 |
95 | doxorubicin metabolic process (GO:0044598) | 3.50365447 |
96 | positive regulation of icosanoid secretion (GO:0032305) | 3.50007252 |
97 | postsynaptic membrane organization (GO:0001941) | 3.47210031 |
98 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.45510227 |
99 | transmission of nerve impulse (GO:0019226) | 3.44067670 |
100 | nucleotide salvage (GO:0043173) | 3.43885518 |
101 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.42854615 |
102 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.38653623 |
103 | deoxyribose phosphate catabolic process (GO:0046386) | 3.38583154 |
104 | aerobic respiration (GO:0009060) | 3.36783789 |
105 | sexual reproduction (GO:0019953) | 3.35022615 |
106 | neuronal action potential propagation (GO:0019227) | 3.34130538 |
107 | cell communication by electrical coupling (GO:0010644) | 3.33768880 |
108 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.30571540 |
109 | positive regulation of antigen processing and presentation (GO:0002579) | 3.30187447 |
110 | positive regulation of synaptic transmission (GO:0050806) | 3.30068810 |
111 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.29686808 |
112 | dendritic spine morphogenesis (GO:0060997) | 3.29264987 |
113 | immunoglobulin mediated immune response (GO:0016064) | 3.28888294 |
114 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.28710689 |
115 | neuromuscular process controlling balance (GO:0050885) | 3.28679582 |
116 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.28318290 |
117 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.28246365 |
118 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.26511200 |
119 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.24575958 |
120 | cAMP-mediated signaling (GO:0019933) | 3.24517216 |
121 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.23928487 |
122 | response to auditory stimulus (GO:0010996) | 3.23255885 |
123 | potassium ion import (GO:0010107) | 3.22182619 |
124 | long-term memory (GO:0007616) | 3.21795411 |
125 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 3.21599455 |
126 | glutamate receptor signaling pathway (GO:0007215) | 3.20868704 |
127 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.20670131 |
128 | glycine transport (GO:0015816) | 3.20216738 |
129 | synaptic transmission, glutamatergic (GO:0035249) | 3.20149566 |
130 | negative regulation of Notch signaling pathway (GO:0045746) | 3.19391971 |
131 | regulation of vesicle fusion (GO:0031338) | 3.18052156 |
132 | dendrite morphogenesis (GO:0048813) | 3.17056681 |
133 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.16485518 |
134 | positive regulation of fatty acid transport (GO:2000193) | 3.16033183 |
135 | negative regulation of telomere maintenance (GO:0032205) | 3.15626032 |
136 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.15397467 |
137 | positive regulation of B cell differentiation (GO:0045579) | 3.12606290 |
138 | regulation of feeding behavior (GO:0060259) | 3.12225322 |
139 | organelle transport along microtubule (GO:0072384) | 3.11501947 |
140 | mitochondrial calcium ion homeostasis (GO:0051560) | 3.09728988 |
141 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.08324029 |
142 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.08237568 |
143 | potassium ion homeostasis (GO:0055075) | 3.06901875 |
144 | macrophage differentiation (GO:0030225) | 3.06094633 |
145 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.05959663 |
146 | * grooming behavior (GO:0007625) | 3.05466497 |
147 | regulation of microtubule-based movement (GO:0060632) | 3.04813212 |
148 | establishment of mitochondrion localization (GO:0051654) | 2.99608005 |
149 | regulation of icosanoid secretion (GO:0032303) | 2.99298184 |
150 | negative regulation of peptide secretion (GO:0002792) | 2.98201484 |
151 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.97971888 |
152 | thrombin receptor signaling pathway (GO:0070493) | 2.97452387 |
153 | GPI anchor biosynthetic process (GO:0006506) | 2.95873782 |
154 | cell differentiation involved in metanephros development (GO:0072202) | 2.95645487 |
155 | * hyperosmotic salinity response (GO:0042538) | 2.95628039 |
156 | regulation of antigen processing and presentation (GO:0002577) | 2.94971851 |
157 | regulation of respiratory burst (GO:0060263) | 2.94429322 |
158 | pentose metabolic process (GO:0019321) | 2.93940788 |
159 | zinc ion transmembrane transport (GO:0071577) | 2.91457537 |
160 | monoamine transport (GO:0015844) | 2.90644170 |
161 | oxygen transport (GO:0015671) | 2.89666625 |
162 | anterograde axon cargo transport (GO:0008089) | 2.88652448 |
163 | GMP metabolic process (GO:0046037) | 2.85945847 |
164 | synaptic vesicle endocytosis (GO:0048488) | 2.85409136 |
165 | membrane hyperpolarization (GO:0060081) | 2.85403222 |
166 | dosage compensation (GO:0007549) | 2.85394671 |
167 | alanine transport (GO:0032328) | 2.84614568 |
168 | autophagic vacuole fusion (GO:0000046) | 2.84321432 |
169 | * female mating behavior (GO:0060180) | 2.84027111 |
170 | drinking behavior (GO:0042756) | 2.82927917 |
171 | neuron-neuron synaptic transmission (GO:0007270) | 2.82631686 |
172 | regulation of skeletal muscle contraction (GO:0014819) | 2.82162122 |
173 | * intraspecies interaction between organisms (GO:0051703) | 2.81589630 |
174 | * social behavior (GO:0035176) | 2.81589630 |
175 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.81319865 |
176 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.81318647 |
177 | membrane depolarization during action potential (GO:0086010) | 2.81286501 |
178 | regulation of synaptic transmission (GO:0050804) | 2.80869100 |
179 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.80647081 |
180 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.79432749 |
181 | neuronal ion channel clustering (GO:0045161) | 2.79076752 |
182 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.78363782 |
183 | negative regulation of amino acid transport (GO:0051956) | 2.76463086 |
184 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.75964343 |
185 | cellular response to glucagon stimulus (GO:0071377) | 2.75624832 |
186 | positive regulation of mRNA catabolic process (GO:0061014) | 2.75251993 |
187 | regulation of ARF protein signal transduction (GO:0032012) | 2.74171094 |
188 | ubiquinone biosynthetic process (GO:0006744) | 2.73389696 |
189 | sleep (GO:0030431) | 2.71930381 |
190 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.71101688 |
191 | somatic stem cell division (GO:0048103) | 2.71038008 |
192 | signal release (GO:0023061) | 2.68979772 |
193 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.67465304 |
194 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.66095479 |
195 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.65589383 |
196 | regulation of B cell apoptotic process (GO:0002902) | 2.65058865 |
197 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.63130527 |
198 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.63130527 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.66032060 |
2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 5.76640218 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.12590343 |
4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.38420768 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.29620531 |
6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.90800131 |
7 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.84717359 |
8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.20251118 |
9 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.01499287 |
10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.85163205 |
11 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.83351024 |
12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.75881225 |
13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.73065986 |
14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.71588913 |
15 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.63699703 |
16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.63279895 |
17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.59816218 |
18 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.58232709 |
19 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.56470661 |
20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.54871601 |
21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.53209622 |
22 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 2.52857640 |
23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.45282586 |
24 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.44559252 |
25 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.43577380 |
26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.41113645 |
27 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.40374525 |
28 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.40374525 |
29 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.37168034 |
30 | GATA1_22025678_ChIP-Seq_K562_Human | 2.36404867 |
31 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.33772201 |
32 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.33377770 |
33 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.27641165 |
34 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.24778299 |
35 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.23661285 |
36 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.22419113 |
37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19982648 |
38 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.17655626 |
39 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.16266373 |
40 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.14801030 |
41 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.92184879 |
42 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.91802342 |
43 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.90820399 |
44 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.88786532 |
45 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.86765991 |
46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.82019603 |
47 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.81642946 |
48 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.81127347 |
49 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.80303453 |
50 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.77920023 |
51 | MYC_22102868_ChIP-Seq_BL_Human | 1.74487205 |
52 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.73883548 |
53 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.73050553 |
54 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.70490750 |
55 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.70354082 |
56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69415527 |
57 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.69411302 |
58 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.67566942 |
59 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.67007723 |
60 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.66360329 |
61 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.64149401 |
62 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.64033592 |
63 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.63594180 |
64 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.56816320 |
65 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.54876915 |
66 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.53323450 |
67 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.52776422 |
68 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.52758817 |
69 | P68_20966046_ChIP-Seq_HELA_Human | 1.52524471 |
70 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.52404835 |
71 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52397940 |
72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51925632 |
73 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.49632212 |
74 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.48304023 |
75 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.47888487 |
76 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.45239287 |
77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.44873536 |
78 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.42095800 |
79 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.41997885 |
80 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.41619741 |
81 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.40641997 |
82 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.38457389 |
83 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.37687462 |
84 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.37237711 |
85 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.36136385 |
86 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.34358624 |
87 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.33536443 |
88 | KDM2B_26808549_Chip-Seq_K562_Human | 1.31991750 |
89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31609265 |
90 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.31443789 |
91 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.31208020 |
92 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29681302 |
93 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.28164991 |
94 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27777174 |
95 | P300_27268052_Chip-Seq_Bcells_Human | 1.26662344 |
96 | * MYB_26560356_Chip-Seq_TH2_Human | 1.26440901 |
97 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.25753754 |
98 | MAF_26560356_Chip-Seq_TH1_Human | 1.25661432 |
99 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24843233 |
100 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.24828946 |
101 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.24492849 |
102 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.24368858 |
103 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23164923 |
104 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23104014 |
105 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.22328622 |
106 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.22125527 |
107 | * ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.22034923 |
108 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.20914080 |
109 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20885526 |
110 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.20695199 |
111 | MAF_26560356_Chip-Seq_TH2_Human | 1.19264032 |
112 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.19256010 |
113 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.19088212 |
114 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.18084095 |
115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.18056884 |
116 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.16034517 |
117 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.14577974 |
118 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.14208301 |
119 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11917118 |
120 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.11318261 |
121 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.11151925 |
122 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.10861774 |
123 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10479500 |
124 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.10360522 |
125 | AR_25329375_ChIP-Seq_VCAP_Human | 1.09946775 |
126 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.09720744 |
127 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.09428487 |
128 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.09363714 |
129 | P300_19829295_ChIP-Seq_ESCs_Human | 1.09113910 |
130 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.08876884 |
131 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.07848236 |
132 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.07792814 |
133 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.07271593 |
134 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.04381433 |
135 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.04375054 |
136 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04278300 |
137 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.04202944 |
138 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.03981538 |
139 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.03933464 |
140 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03878182 |
141 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.03634832 |
142 | AR_19668381_ChIP-Seq_PC3_Human | 1.03346943 |
143 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.03240786 |
144 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.02882601 |
145 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02129281 |
146 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.02117129 |
147 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01999156 |
148 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01549239 |
149 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.00557038 |
150 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.00234428 |
151 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.00058103 |
152 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99966835 |
153 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.99453758 |
154 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.98845046 |
155 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.98378522 |
156 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.98177981 |
157 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98115147 |
158 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.97529564 |
159 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96707105 |
160 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.96627973 |
161 | MYB_26560356_Chip-Seq_TH1_Human | 0.96219545 |
162 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95807578 |
163 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95208517 |
164 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93565853 |
165 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92801700 |
166 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.92341155 |
167 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90260409 |
168 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.87275682 |
169 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.86489009 |
170 | TCF4_23295773_ChIP-Seq_U87_Human | 0.85854880 |
171 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85103719 |
172 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.85095838 |
173 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.85081267 |
174 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84962689 |
175 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84537720 |
176 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.84197178 |
177 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.84078033 |
178 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83677397 |
179 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.83197550 |
180 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.82795752 |
181 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.82206702 |
182 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82113464 |
183 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.81765698 |
184 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.81524828 |
185 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.80989760 |
186 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79071346 |
187 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.78773514 |
188 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.78667187 |
189 | STAT3_23295773_ChIP-Seq_U87_Human | 0.77835190 |
190 | JUN_21703547_ChIP-Seq_K562_Human | 0.76572111 |
191 | * ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.76492895 |
192 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.76203155 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0009278_abnormal_bone_marrow | 7.56005204 |
2 | MP0002163_abnormal_gland_morphology | 5.31725931 |
3 | MP0005397_hematopoietic_system_phenotyp | 4.94024106 |
4 | MP0001545_abnormal_hematopoietic_system | 4.94024106 |
5 | MP0003806_abnormal_nucleotide_metabolis | 4.76011109 |
6 | MP0004859_abnormal_synaptic_plasticity | 4.66668646 |
7 | MP0003122_maternal_imprinting | 4.53492135 |
8 | MP0003880_abnormal_central_pattern | 4.41164122 |
9 | MP0000465_gastrointestinal_hemorrhage | 4.19769075 |
10 | MP0005379_endocrine/exocrine_gland_phen | 3.82995324 |
11 | MP0002234_abnormal_pharynx_morphology | 3.57375654 |
12 | MP0003635_abnormal_synaptic_transmissio | 3.41833515 |
13 | MP0005423_abnormal_somatic_nervous | 3.20050742 |
14 | * MP0005645_abnormal_hypothalamus_physiol | 3.13640340 |
15 | MP0006292_abnormal_olfactory_placode | 2.98489627 |
16 | MP0002064_seizures | 2.84716205 |
17 | MP0009745_abnormal_behavioral_response | 2.84092338 |
18 | MP0001968_abnormal_touch/_nociception | 2.69840138 |
19 | MP0003718_maternal_effect | 2.62226874 |
20 | MP0004270_analgesia | 2.53046933 |
21 | MP0002063_abnormal_learning/memory/cond | 2.47046113 |
22 | MP0009046_muscle_twitch | 2.45419701 |
23 | MP0003191_abnormal_cellular_cholesterol | 2.37855029 |
24 | MP0002734_abnormal_mechanical_nocicepti | 2.35227706 |
25 | MP0006276_abnormal_autonomic_nervous | 2.30095359 |
26 | MP0002572_abnormal_emotion/affect_behav | 2.22809219 |
27 | MP0003866_abnormal_defecation | 2.18360857 |
28 | MP0003123_paternal_imprinting | 2.06410994 |
29 | MP0001502_abnormal_circadian_rhythm | 2.03561982 |
30 | MP0002272_abnormal_nervous_system | 2.02349233 |
31 | MP0002132_abnormal_respiratory_system | 2.02203528 |
32 | MP0005646_abnormal_pituitary_gland | 2.02157469 |
33 | MP0000751_myopathy | 1.99896107 |
34 | MP0001501_abnormal_sleep_pattern | 1.99372717 |
35 | MP0005464_abnormal_platelet_physiology | 1.98899818 |
36 | MP0008004_abnormal_stomach_pH | 1.96687362 |
37 | MP0001835_abnormal_antigen_presentation | 1.95897424 |
38 | MP0005084_abnormal_gallbladder_morpholo | 1.92232449 |
39 | MP0001984_abnormal_olfaction | 1.91401314 |
40 | MP0003787_abnormal_imprinting | 1.91082272 |
41 | MP0003329_amyloid_beta_deposits | 1.88980510 |
42 | MP0002653_abnormal_ependyma_morphology | 1.86826805 |
43 | MP0002736_abnormal_nociception_after | 1.82712366 |
44 | MP0003724_increased_susceptibility_to | 1.79376297 |
45 | MP0001970_abnormal_pain_threshold | 1.78576424 |
46 | MP0001440_abnormal_grooming_behavior | 1.77514176 |
47 | MP0008961_abnormal_basal_metabolism | 1.75457364 |
48 | MP0005623_abnormal_meninges_morphology | 1.75134409 |
49 | MP0002733_abnormal_thermal_nociception | 1.74994416 |
50 | MP0001664_abnormal_digestion | 1.72485482 |
51 | MP0003121_genomic_imprinting | 1.70940172 |
52 | MP0001486_abnormal_startle_reflex | 1.67887788 |
53 | MP0002396_abnormal_hematopoietic_system | 1.66000737 |
54 | MP0004142_abnormal_muscle_tone | 1.62451504 |
55 | MP0002148_abnormal_hypersensitivity_rea | 1.60105513 |
56 | MP0003868_abnormal_feces_composition | 1.59885415 |
57 | MP0002067_abnormal_sensory_capabilities | 1.59178418 |
58 | MP0004858_abnormal_nervous_system | 1.58208062 |
59 | MP0003690_abnormal_glial_cell | 1.53428012 |
60 | MP0009697_abnormal_copulation | 1.53239257 |
61 | MP0002735_abnormal_chemical_nociception | 1.52545920 |
62 | MP0000778_abnormal_nervous_system | 1.51381266 |
63 | MP0008058_abnormal_DNA_repair | 1.48415912 |
64 | MP0005367_renal/urinary_system_phenotyp | 1.44594372 |
65 | MP0000516_abnormal_urinary_system | 1.44594372 |
66 | MP0009840_abnormal_foam_cell | 1.44434690 |
67 | MP0002557_abnormal_social/conspecific_i | 1.43100354 |
68 | MP0006036_abnormal_mitochondrial_physio | 1.43044118 |
69 | MP0002184_abnormal_innervation | 1.42492200 |
70 | MP0000681_abnormal_thyroid_gland | 1.42379824 |
71 | MP0009379_abnormal_foot_pigmentation | 1.41823357 |
72 | MP0008569_lethality_at_weaning | 1.41549707 |
73 | MP0009780_abnormal_chondrocyte_physiolo | 1.41309863 |
74 | MP0003283_abnormal_digestive_organ | 1.38014955 |
75 | MP0002909_abnormal_adrenal_gland | 1.35108756 |
76 | MP0004811_abnormal_neuron_physiology | 1.31944032 |
77 | MP0005025_abnormal_response_to | 1.31618388 |
78 | MP0004885_abnormal_endolymph | 1.29979951 |
79 | MP0003436_decreased_susceptibility_to | 1.28410563 |
80 | MP0000955_abnormal_spinal_cord | 1.25001680 |
81 | MP0004808_abnormal_hematopoietic_stem | 1.23490470 |
82 | MP0002066_abnormal_motor_capabilities/c | 1.22924889 |
83 | MP0005000_abnormal_immune_tolerance | 1.22913192 |
84 | MP0008875_abnormal_xenobiotic_pharmacok | 1.22221206 |
85 | MP0001764_abnormal_homeostasis | 1.21699810 |
86 | MP0002837_dystrophic_cardiac_calcinosis | 1.20279541 |
87 | MP0002876_abnormal_thyroid_physiology | 1.17376252 |
88 | MP0002398_abnormal_bone_marrow | 1.17026443 |
89 | MP0000639_abnormal_adrenal_gland | 1.16864509 |
90 | MP0004924_abnormal_behavior | 1.14983605 |
91 | MP0005386_behavior/neurological_phenoty | 1.14983605 |
92 | MP0003763_abnormal_thymus_physiology | 1.13059046 |
93 | MP0000631_abnormal_neuroendocrine_gland | 1.13023058 |
94 | MP0002882_abnormal_neuron_morphology | 1.12149452 |
95 | MP0008057_abnormal_DNA_replication | 1.11024242 |
96 | MP0002019_abnormal_tumor_incidence | 1.10359071 |
97 | MP0003186_abnormal_redox_activity | 1.10115433 |
98 | MP0002420_abnormal_adaptive_immunity | 1.09681293 |
99 | MP0001819_abnormal_immune_cell | 1.09377883 |
100 | MP0002822_catalepsy | 1.09020023 |
101 | MP0000689_abnormal_spleen_morphology | 1.08028405 |
102 | MP0001666_abnormal_nutrient_absorption | 1.06293490 |
103 | MP0000747_muscle_weakness | 1.06164418 |
104 | MP0000490_abnormal_crypts_of | 1.05818391 |
105 | MP0002452_abnormal_antigen_presenting | 1.05156335 |
106 | MP0001881_abnormal_mammary_gland | 1.05155881 |
107 | MP0000716_abnormal_immune_system | 1.03197736 |
108 | MP0002723_abnormal_immune_serum | 1.02808215 |
109 | MP0005167_abnormal_blood-brain_barrier | 1.02711260 |
110 | MP0002419_abnormal_innate_immunity | 1.01927722 |
111 | MP0000604_amyloidosis | 1.01404174 |
112 | MP0003633_abnormal_nervous_system | 1.00176481 |
113 | MP0010368_abnormal_lymphatic_system | 0.97553197 |
114 | MP0005670_abnormal_white_adipose | 0.97153897 |
115 | MP0004145_abnormal_muscle_electrophysio | 0.96418585 |
116 | MP0000013_abnormal_adipose_tissue | 0.94118529 |
117 | MP0002429_abnormal_blood_cell | 0.93316943 |
118 | MP0001529_abnormal_vocalization | 0.92140905 |
119 | MP0003634_abnormal_glial_cell | 0.92109046 |
120 | * MP0002152_abnormal_brain_morphology | 0.90677164 |
121 | MP0005394_taste/olfaction_phenotype | 0.89435825 |
122 | MP0005499_abnormal_olfactory_system | 0.89435825 |
123 | MP0002229_neurodegeneration | 0.88452866 |
124 | MP0001905_abnormal_dopamine_level | 0.88056044 |
125 | MP0009765_abnormal_xenobiotic_induced | 0.87156190 |
126 | MP0000920_abnormal_myelination | 0.86941167 |
127 | MP0005410_abnormal_fertilization | 0.86556504 |
128 | MP0003075_altered_response_to | 0.85995782 |
129 | MP0002638_abnormal_pupillary_reflex | 0.85636822 |
130 | * MP0002069_abnormal_eating/drinking_beha | 0.85232962 |
131 | MP0003631_nervous_system_phenotype | 0.83785089 |
132 | MP0002722_abnormal_immune_system | 0.83736716 |
133 | MP0000613_abnormal_salivary_gland | 0.82088490 |
134 | MP0001346_abnormal_lacrimal_gland | 0.81522857 |
135 | MP0009785_altered_susceptibility_to | 0.81522274 |
136 | MP0008872_abnormal_physiological_respon | 0.81175059 |
137 | MP0008469_abnormal_protein_level | 0.80733072 |
138 | MP0003959_abnormal_lean_body | 0.80413978 |
139 | MP0009333_abnormal_splenocyte_physiolog | 0.79378721 |
140 | MP0001299_abnormal_eye_distance/ | 0.78953571 |
141 | MP0002928_abnormal_bile_duct | 0.78630418 |
142 | MP0005220_abnormal_exocrine_pancreas | 0.78464984 |
143 | MP0000685_abnormal_immune_system | 0.77723279 |
144 | MP0001188_hyperpigmentation | 0.77299933 |
145 | MP0003879_abnormal_hair_cell | 0.77164078 |
146 | MP0005387_immune_system_phenotype | 0.77129947 |
147 | MP0001790_abnormal_immune_system | 0.77129947 |
148 | MP0005395_other_phenotype | 0.77092042 |
149 | MP0005535_abnormal_body_temperature | 0.76799508 |
150 | MP0003137_abnormal_impulse_conducting | 0.76444998 |
151 | MP0001800_abnormal_humoral_immune | 0.76268853 |
152 | MP0005266_abnormal_metabolism | 0.76083156 |
153 | MP0001177_atelectasis | 0.75323171 |
154 | MP0009764_decreased_sensitivity_to | 0.75187344 |
155 | MP0003632_abnormal_nervous_system | 0.72260781 |
156 | MP0008995_early_reproductive_senescence | 0.71781794 |
157 | MP0008873_increased_physiological_sensi | 0.70773290 |
158 | MP0001851_eye_inflammation | 0.69661229 |
159 | MP0000678_abnormal_parathyroid_gland | 0.69493417 |
160 | MP0006072_abnormal_retinal_apoptosis | 0.69221331 |
161 | MP0001986_abnormal_taste_sensitivity | 0.68864742 |
162 | MP0003303_peritoneal_inflammation | 0.68530576 |
163 | MP0010386_abnormal_urinary_bladder | 0.67759136 |
164 | MP0005165_increased_susceptibility_to | 0.67036221 |
165 | MP0001845_abnormal_inflammatory_respons | 0.66730657 |
166 | MP0004272_abnormal_basement_membrane | 0.66127502 |
167 | MP0010155_abnormal_intestine_physiology | 0.65280725 |
168 | MP0000647_abnormal_sebaceous_gland | 0.65245988 |
169 | MP0005058_abnormal_lysosome_morphology | 0.65195022 |
170 | MP0000230_abnormal_systemic_arterial | 0.64760207 |
171 | MP0008874_decreased_physiological_sensi | 0.64535981 |
172 | MP0008877_abnormal_DNA_methylation | 0.64319898 |
173 | MP0003943_abnormal_hepatobiliary_system | 0.64094414 |
174 | MP0002332_abnormal_exercise_endurance | 0.63115532 |
175 | MP0002089_abnormal_postnatal_growth/wei | 0.62000011 |
176 | MP0005075_abnormal_melanosome_morpholog | 0.61981707 |
177 | MP0000003_abnormal_adipose_tissue | 0.61861597 |
178 | MP0008007_abnormal_cellular_replicative | 0.61530425 |
179 | MP0009763_increased_sensitivity_to | 0.61399294 |
180 | MP0004147_increased_porphyrin_level | 0.60662491 |
181 | MP0005330_cardiomyopathy | 0.58769958 |
182 | MP0005551_abnormal_eye_electrophysiolog | 0.58514580 |
183 | MP0003172_abnormal_lysosome_physiology | 0.57204405 |
184 | MP0001943_abnormal_respiration | 0.56624451 |
185 | MP0001348_abnormal_lacrimal_gland | 0.51276804 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Anosmia (HP:0000458) | 5.96196359 |
2 | Atonic seizures (HP:0010819) | 5.70059117 |
3 | Stomatitis (HP:0010280) | 4.86580560 |
4 | Focal seizures (HP:0007359) | 4.86233879 |
5 | Thrombocytosis (HP:0001894) | 4.61946829 |
6 | Abnormal eating behavior (HP:0100738) | 4.59487591 |
7 | Polyphagia (HP:0002591) | 4.57959205 |
8 | Myokymia (HP:0002411) | 4.53883453 |
9 | Focal motor seizures (HP:0011153) | 4.43633893 |
10 | Absence seizures (HP:0002121) | 4.35596642 |
11 | Supranuclear gaze palsy (HP:0000605) | 4.22837377 |
12 | Febrile seizures (HP:0002373) | 3.91695093 |
13 | Generalized tonic-clonic seizures (HP:0002069) | 3.90812265 |
14 | Increased intramyocellular lipid droplets (HP:0012240) | 3.85858896 |
15 | Hypogonadotrophic hypogonadism (HP:0000044) | 3.85396178 |
16 | Visual hallucinations (HP:0002367) | 3.82901857 |
17 | Increased muscle lipid content (HP:0009058) | 3.82852031 |
18 | Microvesicular hepatic steatosis (HP:0001414) | 3.70567422 |
19 | Hypertensive crisis (HP:0100735) | 3.69692108 |
20 | Ankle clonus (HP:0011448) | 3.66968896 |
21 | Mutism (HP:0002300) | 3.62627162 |
22 | Dialeptic seizures (HP:0011146) | 3.62585183 |
23 | Failure to thrive in infancy (HP:0001531) | 3.58247650 |
24 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.53189229 |
25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.51131756 |
26 | Rhabdomyolysis (HP:0003201) | 3.48478361 |
27 | Metaphyseal dysplasia (HP:0100255) | 3.43406699 |
28 | Myoglobinuria (HP:0002913) | 3.41668383 |
29 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.40287339 |
30 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.39651085 |
31 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.39651085 |
32 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.38031690 |
33 | Agammaglobulinemia (HP:0004432) | 3.30821389 |
34 | Spontaneous abortion (HP:0005268) | 3.28494909 |
35 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.28095483 |
36 | Cerebral aneurysm (HP:0004944) | 3.25771763 |
37 | Seborrheic dermatitis (HP:0001051) | 3.21202025 |
38 | Anxiety (HP:0000739) | 3.19738106 |
39 | Chronic obstructive pulmonary disease (HP:0006510) | 3.16507016 |
40 | Obstructive lung disease (HP:0006536) | 3.16507016 |
41 | Panhypogammaglobulinemia (HP:0003139) | 3.15444065 |
42 | Hyperglycinuria (HP:0003108) | 3.12767255 |
43 | Oligomenorrhea (HP:0000876) | 3.08749390 |
44 | Neurofibrillary tangles (HP:0002185) | 3.07972117 |
45 | Agitation (HP:0000713) | 3.07393893 |
46 | Hyperglycinemia (HP:0002154) | 3.04727878 |
47 | Diaphragmatic weakness (HP:0009113) | 3.03313740 |
48 | Dicarboxylic aciduria (HP:0003215) | 3.00889299 |
49 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.00889299 |
50 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.98146751 |
51 | Epileptic encephalopathy (HP:0200134) | 2.95113779 |
52 | Ventricular fibrillation (HP:0001663) | 2.94399092 |
53 | Truncal ataxia (HP:0002078) | 2.93695133 |
54 | Insomnia (HP:0100785) | 2.93309295 |
55 | Depression (HP:0000716) | 2.93033730 |
56 | Abnormal pupillary function (HP:0007686) | 2.93001015 |
57 | Progressive inability to walk (HP:0002505) | 2.90902143 |
58 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.87621832 |
59 | Neuronal loss in central nervous system (HP:0002529) | 2.84943148 |
60 | Aplastic anemia (HP:0001915) | 2.83661739 |
61 | Dysmetria (HP:0001310) | 2.82594898 |
62 | Xerostomia (HP:0000217) | 2.81024389 |
63 | Hepatocellular necrosis (HP:0001404) | 2.78680890 |
64 | Hypoventilation (HP:0002791) | 2.77540135 |
65 | Decreased central vision (HP:0007663) | 2.76712769 |
66 | Hyperthyroidism (HP:0000836) | 2.75042300 |
67 | Psychosis (HP:0000709) | 2.72879388 |
68 | Type I transferrin isoform profile (HP:0003642) | 2.70247579 |
69 | Spastic gait (HP:0002064) | 2.68850512 |
70 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.66320211 |
71 | Papilledema (HP:0001085) | 2.65908014 |
72 | Areflexia of lower limbs (HP:0002522) | 2.64148155 |
73 | Pheochromocytoma (HP:0002666) | 2.64018044 |
74 | Dysautonomia (HP:0002459) | 2.63550034 |
75 | Abnormal hair whorl (HP:0010721) | 2.60937300 |
76 | Postural instability (HP:0002172) | 2.58898027 |
77 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.58174234 |
78 | Dysdiadochokinesis (HP:0002075) | 2.58084551 |
79 | Hepatosplenomegaly (HP:0001433) | 2.57900076 |
80 | Cerebral inclusion bodies (HP:0100314) | 2.57628573 |
81 | Hepatic necrosis (HP:0002605) | 2.57031256 |
82 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.55796294 |
83 | Increased cerebral lipofuscin (HP:0011813) | 2.55253020 |
84 | Hemiplegia (HP:0002301) | 2.53805455 |
85 | Abnormality of the labia minora (HP:0012880) | 2.52829936 |
86 | Prolonged bleeding time (HP:0003010) | 2.50227140 |
87 | Abnormality of B cell number (HP:0010975) | 2.50089403 |
88 | Macroorchidism (HP:0000053) | 2.49980238 |
89 | Mediastinal lymphadenopathy (HP:0100721) | 2.48378657 |
90 | Diplopia (HP:0000651) | 2.48039744 |
91 | Abnormality of binocular vision (HP:0011514) | 2.48039744 |
92 | Abnormality of pain sensation (HP:0010832) | 2.48031190 |
93 | Impaired pain sensation (HP:0007328) | 2.48031190 |
94 | Abnormality of the lower motor neuron (HP:0002366) | 2.46598818 |
95 | Exercise-induced myalgia (HP:0003738) | 2.46004974 |
96 | Neuroendocrine neoplasm (HP:0100634) | 2.45411157 |
97 | Generalized hypotonia (HP:0001290) | 2.43792215 |
98 | Mitochondrial inheritance (HP:0001427) | 2.42674374 |
99 | Hypercortisolism (HP:0001578) | 2.42263452 |
100 | Abnormality of glycine metabolism (HP:0010895) | 2.41603717 |
101 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.41603717 |
102 | Ketoacidosis (HP:0001993) | 2.39544650 |
103 | Urticaria (HP:0001025) | 2.38871896 |
104 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.38585913 |
105 | Increased IgM level (HP:0003496) | 2.35274441 |
106 | Hemiparesis (HP:0001269) | 2.34604335 |
107 | Congenital stationary night blindness (HP:0007642) | 2.34274907 |
108 | Lower limb muscle weakness (HP:0007340) | 2.32185372 |
109 | Narrow nasal bridge (HP:0000446) | 2.29918676 |
110 | Recurrent fungal infections (HP:0002841) | 2.29638915 |
111 | Ragged-red muscle fibers (HP:0003200) | 2.29421287 |
112 | Abnormal protein glycosylation (HP:0012346) | 2.29273883 |
113 | Abnormal glycosylation (HP:0012345) | 2.29273883 |
114 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.29273883 |
115 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.29273883 |
116 | Progressive cerebellar ataxia (HP:0002073) | 2.28893502 |
117 | Action tremor (HP:0002345) | 2.28659559 |
118 | Bradykinesia (HP:0002067) | 2.27365098 |
119 | Epistaxis (HP:0000421) | 2.26738543 |
120 | Sleep apnea (HP:0010535) | 2.26112523 |
121 | Menstrual irregularities (HP:0000858) | 2.22342073 |
122 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.20884177 |
123 | Aplasia of the phalanges of the hand (HP:0009802) | 2.20884177 |
124 | Aplasia involving bones of the extremities (HP:0009825) | 2.20884177 |
125 | Poor eye contact (HP:0000817) | 2.19924290 |
126 | Clonus (HP:0002169) | 2.19775431 |
127 | Pancytopenia (HP:0001876) | 2.19213322 |
128 | Muscle fiber atrophy (HP:0100295) | 2.18984717 |
129 | Impaired social interactions (HP:0000735) | 2.18270025 |
130 | Abnormal social behavior (HP:0012433) | 2.18270025 |
131 | Recurrent viral infections (HP:0004429) | 2.17881177 |
132 | Chronic otitis media (HP:0000389) | 2.16393335 |
133 | B lymphocytopenia (HP:0010976) | 2.16291654 |
134 | Fatigue (HP:0012378) | 2.15909853 |
135 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.15362789 |
136 | Slow saccadic eye movements (HP:0000514) | 2.12037174 |
137 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.11962337 |
138 | Orthostatic hypotension (HP:0001278) | 2.11011258 |
139 | Broad-based gait (HP:0002136) | 2.08800087 |
140 | Ulnar claw (HP:0001178) | 2.08372386 |
141 | Tubulointerstitial nephritis (HP:0001970) | 2.06717333 |
142 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.06283907 |
143 | Excessive salivation (HP:0003781) | 2.06116925 |
144 | Drooling (HP:0002307) | 2.06116925 |
145 | Urinary urgency (HP:0000012) | 2.05601906 |
146 | Sensorimotor neuropathy (HP:0007141) | 2.05426530 |
147 | Petechiae (HP:0000967) | 2.04755015 |
148 | Torticollis (HP:0000473) | 2.03950779 |
149 | Myositis (HP:0100614) | 2.03669982 |
150 | Turricephaly (HP:0000262) | 2.02766854 |
151 | Abnormality of saccadic eye movements (HP:0000570) | 2.02313820 |
152 | Abnormality of the prostate (HP:0008775) | 2.01342078 |
153 | Restlessness (HP:0000711) | 1.99995526 |
154 | Intention tremor (HP:0002080) | 1.99521911 |
155 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.99326542 |
156 | Abnormality of macular pigmentation (HP:0008002) | 1.98589649 |
157 | Hypergammaglobulinemia (HP:0010702) | 1.98343172 |
158 | Peripheral hypomyelination (HP:0007182) | 1.97831824 |
159 | Stomach cancer (HP:0012126) | 1.97420025 |
160 | Cellulitis (HP:0100658) | 1.96677558 |
161 | Reduced antithrombin III activity (HP:0001976) | 1.96275761 |
162 | Muscle stiffness (HP:0003552) | 1.95685754 |
163 | Flat capital femoral epiphysis (HP:0003370) | 1.95306582 |
164 | Abnormal EKG (HP:0003115) | 1.95105302 |
165 | Megalencephaly (HP:0001355) | 1.93996184 |
166 | Cleft eyelid (HP:0000625) | 1.93575678 |
167 | Exercise intolerance (HP:0003546) | 1.91843520 |
168 | Progressive microcephaly (HP:0000253) | 1.91075474 |
169 | Apathy (HP:0000741) | 1.90977809 |
170 | Chest pain (HP:0100749) | 1.90796710 |
171 | Poor suck (HP:0002033) | 1.89468092 |
172 | Ketosis (HP:0001946) | 1.89253329 |
173 | Gingival bleeding (HP:0000225) | 1.88925418 |
174 | Open mouth (HP:0000194) | 1.87761576 |
175 | Genetic anticipation (HP:0003743) | 1.87004689 |
176 | Cerebral palsy (HP:0100021) | 1.86884488 |
177 | Termporal pattern (HP:0011008) | 1.83914956 |
178 | Insidious onset (HP:0003587) | 1.83914956 |
179 | Craniofacial dystonia (HP:0012179) | 1.83429189 |
180 | Amyotrophic lateral sclerosis (HP:0007354) | 1.82982804 |
181 | Rapidly progressive (HP:0003678) | 1.82945639 |
182 | Postural tremor (HP:0002174) | 1.81895986 |
183 | Abnormality of T cell physiology (HP:0011840) | 1.81549590 |
184 | Status epilepticus (HP:0002133) | 1.81540292 |
185 | Focal dystonia (HP:0004373) | 1.81174711 |
186 | Episodic fever (HP:0001954) | 1.80649583 |
187 | Prolonged neonatal jaundice (HP:0006579) | 1.80069648 |
188 | Stroke (HP:0001297) | 1.79889965 |
189 | Acute hepatic failure (HP:0006554) | 1.79506880 |
190 | Rigidity (HP:0002063) | 1.79430527 |
191 | Meningitis (HP:0001287) | 1.79193746 |
192 | Exertional dyspnea (HP:0002875) | 1.79086037 |
193 | Slow progression (HP:0003677) | 1.78990902 |
194 | Abnormality of the vocal cords (HP:0008777) | 1.78223416 |
195 | Amelogenesis imperfecta (HP:0000705) | 1.78198655 |
196 | Ventricular arrhythmia (HP:0004308) | 1.77721304 |
197 | Amaurosis fugax (HP:0100576) | 1.76604382 |
198 | Abnormality of the tricuspid valve (HP:0001702) | 1.75162661 |
199 | Abnormality of the 4th metacarpal (HP:0010012) | 1.74360782 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 5.17399752 |
2 | TAOK3 | 5.11549766 |
3 | MAP4K1 | 4.34605036 |
4 | KDR | 3.74313822 |
5 | MARK1 | 3.70273805 |
6 | NTRK2 | 3.56639769 |
7 | MAP3K12 | 3.26195503 |
8 | MAP3K4 | 3.01194892 |
9 | MINK1 | 2.87734477 |
10 | MAP3K9 | 2.69361561 |
11 | MAP2K4 | 2.62190448 |
12 | VRK2 | 2.61506514 |
13 | EPHA4 | 2.46414159 |
14 | KIT | 2.43839043 |
15 | ZAK | 2.19665932 |
16 | PAK6 | 2.13386111 |
17 | NTRK1 | 2.07918260 |
18 | MAP2K7 | 2.02399044 |
19 | PHKG1 | 1.96310506 |
20 | PHKG2 | 1.96310506 |
21 | TBK1 | 1.94632910 |
22 | DYRK1B | 1.93692232 |
23 | TIE1 | 1.93235848 |
24 | UHMK1 | 1.86785264 |
25 | FLT3 | 1.81540488 |
26 | TNK2 | 1.81178020 |
27 | JAK3 | 1.80202962 |
28 | NUAK1 | 1.79885102 |
29 | TESK2 | 1.79155511 |
30 | NME2 | 1.78911158 |
31 | LMTK2 | 1.73788537 |
32 | PBK | 1.71565692 |
33 | MAP2K3 | 1.55532129 |
34 | CDK5 | 1.52225755 |
35 | CDK19 | 1.49216768 |
36 | LATS2 | 1.49173651 |
37 | DAPK2 | 1.46589914 |
38 | GRK6 | 1.45763913 |
39 | CAMKK1 | 1.45070230 |
40 | MAP3K7 | 1.42785328 |
41 | TAOK2 | 1.41850019 |
42 | PRKD2 | 1.39509252 |
43 | PRKCH | 1.39452201 |
44 | FES | 1.35100108 |
45 | SIK2 | 1.28851872 |
46 | MAP3K14 | 1.24842389 |
47 | PAK3 | 1.23565575 |
48 | TNIK | 1.23296989 |
49 | IKBKB | 1.21992111 |
50 | MAP2K2 | 1.21480851 |
51 | PNCK | 1.21283905 |
52 | CDC42BPA | 1.19962939 |
53 | CAMK2A | 1.15873843 |
54 | RPS6KB2 | 1.15798714 |
55 | TSSK6 | 1.15598593 |
56 | MAPKAPK3 | 1.15310158 |
57 | BTK | 1.14283515 |
58 | ALK | 1.08758426 |
59 | PRKCG | 1.08376724 |
60 | CAMK2B | 1.07921444 |
61 | CAMK1G | 1.06503248 |
62 | PIK3CG | 1.03305806 |
63 | STK4 | 1.03114784 |
64 | PRKD3 | 1.02941388 |
65 | CAMK2G | 1.01997516 |
66 | MATK | 1.01442402 |
67 | GRK5 | 1.00661493 |
68 | MAPK13 | 1.00174255 |
69 | VRK1 | 0.97098137 |
70 | WNK3 | 0.95536268 |
71 | CDC7 | 0.95053854 |
72 | CAMK1 | 0.94939552 |
73 | PIM2 | 0.94587667 |
74 | KSR2 | 0.93759614 |
75 | CAMK2D | 0.92715215 |
76 | OXSR1 | 0.92635311 |
77 | STK11 | 0.87941146 |
78 | STK38 | 0.87727139 |
79 | IKBKE | 0.83417648 |
80 | CAMK1D | 0.81347997 |
81 | TAOK1 | 0.81096543 |
82 | CAMKK2 | 0.80350374 |
83 | MAP3K2 | 0.77498073 |
84 | CSF1R | 0.77347462 |
85 | TEC | 0.76619221 |
86 | SYK | 0.76200029 |
87 | SGK223 | 0.74212364 |
88 | SGK494 | 0.74212364 |
89 | CDK15 | 0.74191740 |
90 | MAPK15 | 0.73312486 |
91 | SCYL2 | 0.71841375 |
92 | CDK18 | 0.71451439 |
93 | CDK14 | 0.71425850 |
94 | MAP3K6 | 0.70883399 |
95 | LIMK1 | 0.70198417 |
96 | FER | 0.69603494 |
97 | TYRO3 | 0.68073071 |
98 | BCKDK | 0.66179763 |
99 | RET | 0.65838910 |
100 | TESK1 | 0.65741913 |
101 | RPS6KA3 | 0.63603530 |
102 | PLK2 | 0.61431110 |
103 | ARAF | 0.61329593 |
104 | PKN1 | 0.61325811 |
105 | RPS6KA5 | 0.59570213 |
106 | CDK11A | 0.59542532 |
107 | BMX | 0.58877033 |
108 | ABL2 | 0.58854748 |
109 | ROCK1 | 0.58068764 |
110 | SMG1 | 0.57981345 |
111 | CHEK2 | 0.57360799 |
112 | BRSK1 | 0.56737537 |
113 | AKT3 | 0.56185391 |
114 | LCK | 0.55766934 |
115 | TLK1 | 0.55494584 |
116 | ATR | 0.55240018 |
117 | MAPK10 | 0.54992421 |
118 | DAPK1 | 0.54574676 |
119 | RPS6KA6 | 0.53180689 |
120 | DDR2 | 0.53077234 |
121 | RPS6KC1 | 0.52752252 |
122 | RPS6KL1 | 0.52752252 |
123 | DYRK1A | 0.51828587 |
124 | MAP3K1 | 0.51604873 |
125 | PRKG2 | 0.51213185 |
126 | FYN | 0.51130963 |
127 | PDPK1 | 0.50415011 |
128 | INSRR | 0.49541164 |
129 | ROCK2 | 0.49211811 |
130 | SGK3 | 0.49199088 |
131 | MARK2 | 0.48670753 |
132 | RPS6KA2 | 0.48669308 |
133 | TXK | 0.48604200 |
134 | MAP2K6 | 0.48395441 |
135 | PRKCA | 0.47028067 |
136 | PIM1 | 0.46766569 |
137 | MAPK3 | 0.46708757 |
138 | PRKCE | 0.46541624 |
139 | CDK9 | 0.46339711 |
140 | CCNB1 | 0.46084797 |
141 | BMPR1B | 0.45063067 |
142 | SGK1 | 0.44157619 |
143 | CDK7 | 0.43911696 |
144 | PDGFRA | 0.43225313 |
145 | MAP3K11 | 0.43122686 |
146 | AURKB | 0.43102620 |
147 | FGFR2 | 0.42843323 |
148 | NEK2 | 0.42513259 |
149 | MAPKAPK5 | 0.41936854 |
150 | GRK7 | 0.41746690 |
151 | PRKACA | 0.41373812 |
152 | CSNK1G2 | 0.41270093 |
153 | PRKACG | 0.40470171 |
154 | ADRBK2 | 0.40392301 |
155 | MAP3K8 | 0.40324121 |
156 | PRKCQ | 0.39765649 |
157 | PRKCD | 0.39538811 |
158 | MAP4K2 | 0.39526413 |
159 | ADRBK1 | 0.39446312 |
160 | MAP3K13 | 0.39032106 |
161 | FGR | 0.38868796 |
162 | NME1 | 0.38682904 |
163 | PRKCZ | 0.38411574 |
164 | ERBB3 | 0.37851746 |
165 | SRC | 0.36887754 |
166 | SGK2 | 0.35976193 |
167 | PDK1 | 0.35862776 |
168 | PRKCB | 0.35782767 |
169 | LRRK2 | 0.35494695 |
170 | MAP3K5 | 0.35373295 |
171 | DAPK3 | 0.33614638 |
172 | DYRK2 | 0.33543021 |
173 | LYN | 0.32840294 |
174 | AKT2 | 0.32704993 |
175 | MAPK11 | 0.32408201 |
176 | MAP3K3 | 0.32400307 |
177 | AURKA | 0.32309486 |
178 | PTK2B | 0.31258176 |
179 | CDK8 | 0.30131111 |
180 | TAF1 | 0.29396474 |
181 | JAK2 | 0.28036496 |
182 | PRKD1 | 0.25334900 |
183 | HIPK2 | 0.24252405 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.16680329 |
2 | GABAergic synapse_Homo sapiens_hsa04727 | 3.80073263 |
3 | Base excision repair_Homo sapiens_hsa03410 | 3.46696153 |
4 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 3.42702943 |
5 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.24264603 |
6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.04321512 |
7 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.01694833 |
8 | Morphine addiction_Homo sapiens_hsa05032 | 2.72275061 |
9 | * Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.71260974 |
10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.52234946 |
11 | Allograft rejection_Homo sapiens_hsa05330 | 2.44649170 |
12 | Olfactory transduction_Homo sapiens_hsa04740 | 2.44455380 |
13 | Asthma_Homo sapiens_hsa05310 | 2.40809277 |
14 | Circadian entrainment_Homo sapiens_hsa04713 | 2.34948870 |
15 | DNA replication_Homo sapiens_hsa03030 | 2.27012474 |
16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.23413286 |
17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.22062204 |
18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.16699649 |
19 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.10648050 |
20 | Ribosome_Homo sapiens_hsa03010 | 2.08845334 |
21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.01658791 |
22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.99888739 |
23 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.98383832 |
24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.94236914 |
25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.93556181 |
26 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.91862481 |
27 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.88178164 |
28 | Taste transduction_Homo sapiens_hsa04742 | 1.85447132 |
29 | Mismatch repair_Homo sapiens_hsa03430 | 1.85291143 |
30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.84826127 |
31 | Long-term potentiation_Homo sapiens_hsa04720 | 1.84465371 |
32 | Insulin secretion_Homo sapiens_hsa04911 | 1.82535120 |
33 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.82385418 |
34 | Salivary secretion_Homo sapiens_hsa04970 | 1.78890798 |
35 | Peroxisome_Homo sapiens_hsa04146 | 1.77697648 |
36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.74978070 |
37 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.71416081 |
38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.70617555 |
39 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.68019860 |
40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.65376174 |
41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64666380 |
42 | Renin secretion_Homo sapiens_hsa04924 | 1.57307956 |
43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.55634405 |
44 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.54872689 |
45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.46310455 |
46 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.46123764 |
47 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.44310663 |
48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.44010340 |
49 | Homologous recombination_Homo sapiens_hsa03440 | 1.43708119 |
50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.40029986 |
51 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.39956740 |
52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.38371254 |
53 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.38216354 |
54 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.37113669 |
55 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.34522464 |
56 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.34235546 |
57 | Long-term depression_Homo sapiens_hsa04730 | 1.33154775 |
58 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.33124224 |
59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30915266 |
60 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.29907194 |
61 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.29049314 |
62 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27873373 |
63 | Bile secretion_Homo sapiens_hsa04976 | 1.27693840 |
64 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.27660672 |
65 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.27650552 |
66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.24187792 |
67 | Leishmaniasis_Homo sapiens_hsa05140 | 1.23860917 |
68 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.22945845 |
69 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.21777278 |
70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.18138600 |
71 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.17977531 |
72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.14895782 |
73 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.14106904 |
74 | Platelet activation_Homo sapiens_hsa04611 | 1.13799226 |
75 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.12325923 |
76 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.11819259 |
77 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.09514815 |
78 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.08301533 |
79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.07136935 |
80 | Prion diseases_Homo sapiens_hsa05020 | 1.03605453 |
81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.00259614 |
82 | Gap junction_Homo sapiens_hsa04540 | 1.00214215 |
83 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.99622559 |
84 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.99336836 |
85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.99169665 |
86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.97847185 |
87 | Phototransduction_Homo sapiens_hsa04744 | 0.97529791 |
88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.95954339 |
89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95658607 |
90 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.94903368 |
91 | Parkinsons disease_Homo sapiens_hsa05012 | 0.94714538 |
92 | Axon guidance_Homo sapiens_hsa04360 | 0.93184593 |
93 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.92363545 |
94 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91547259 |
95 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.91129185 |
96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.90786595 |
97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.89633240 |
98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.88945497 |
99 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.87972223 |
100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.87770672 |
101 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.85998485 |
102 | Alzheimers disease_Homo sapiens_hsa05010 | 0.84714594 |
103 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.83506642 |
104 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.82220236 |
105 | Melanogenesis_Homo sapiens_hsa04916 | 0.82135716 |
106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.81926921 |
107 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.80889684 |
108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.79473401 |
109 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78423216 |
110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.78401173 |
111 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77276283 |
112 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77204598 |
113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75892265 |
114 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75830513 |
115 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.75172932 |
116 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75094194 |
117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75041951 |
118 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.74240969 |
119 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.73821605 |
120 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.73807901 |
121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.73256961 |
122 | Spliceosome_Homo sapiens_hsa03040 | 0.72641187 |
123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.71714764 |
124 | Huntingtons disease_Homo sapiens_hsa05016 | 0.69916488 |
125 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.69721265 |
126 | Purine metabolism_Homo sapiens_hsa00230 | 0.69430860 |
127 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68663905 |
128 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.65477056 |
129 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.64007239 |
130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63946515 |
131 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.63721797 |
132 | Metabolic pathways_Homo sapiens_hsa01100 | 0.63294055 |
133 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62888998 |
134 | RNA degradation_Homo sapiens_hsa03018 | 0.62166189 |
135 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.61260703 |
136 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60433708 |
137 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.59319460 |
138 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.59143413 |
139 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.58797707 |
140 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57995855 |
141 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57945553 |
142 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.57677791 |
143 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56855031 |
144 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56579329 |
145 | Glioma_Homo sapiens_hsa05214 | 0.54788955 |
146 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54666456 |
147 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.52657548 |
148 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.52637004 |
149 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52230397 |
150 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50355088 |
151 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.45379409 |
152 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44571725 |
153 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44316021 |
154 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.43770480 |
155 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43152938 |
156 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42852828 |
157 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40442679 |
158 | Alcoholism_Homo sapiens_hsa05034 | 0.40246554 |
159 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38981055 |
160 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38810474 |
161 | Pertussis_Homo sapiens_hsa05133 | 0.38756229 |
162 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.37148095 |
163 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35485513 |
164 | Influenza A_Homo sapiens_hsa05164 | 0.33074057 |
165 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.32866071 |
166 | Lysosome_Homo sapiens_hsa04142 | 0.32088342 |
167 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.31425922 |
168 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.30201140 |
169 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.29944595 |
170 | Shigellosis_Homo sapiens_hsa05131 | 0.29479703 |
171 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.29327169 |
172 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28984185 |
173 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.28740971 |
174 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.28258472 |
175 | Phagosome_Homo sapiens_hsa04145 | 0.27655405 |
176 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27124613 |
177 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.26286917 |
178 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.25056197 |
179 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.23818279 |
180 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.23590363 |
181 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.21622950 |
182 | Endocytosis_Homo sapiens_hsa04144 | 0.20570031 |
183 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.20496818 |